Search Results - Yanming Hong
- Showing 1 - 1 results of 1
-
1
A Cost-Effectiveness Analysis: First-Line Avelumab Plus Axitinib Versus Sunitinib for Advanced Renal-Cell Carcinoma by Peiyao Lu, Weiting Liang, Jiahao Li, Yanming Hong, Zhuojia Chen, Tao Liu, Pei Dong, Hongbing Huang, Tiantian Zhang, Tiantian Zhang, Jie Jiang, Jie Jiang, Jie Jiang
Published 2020Call Number: Loading…Connect to this object online.
Located: Loading…
Book